Back to results
US 2023/0263757 A1Published application
Disinfecting wipe kit for central venous access devices
AssigneeSterileCare Inc.
InventorKaren Mueller
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions and solutions containing tetrasodium EDTA, ethanol, and chlorhexidine, and optionally taurolidine, heparin, or a thrombolytic agent. The compositions may be disposed on a cleaning wipe to provide broad-spectrum antimicrobial activity on planktonic and biofilm cells of clinically relevant pathogens. Also provided herein is a peripheral line placement kit containing the compositions and solutions.
Claims14
A cleaning wipe kit, the kit comprising:
- at least one first wipe, wherein the first wipe comprises a first composition comprising 1-15% (w/v) tetrasodium EDTA and ethanol, and wherein the composition has a pH of at least 9.5;
- and
- at least one second wipe, wherein the second wipe comprises a second composition comprising 1.0-15% (w/v) tetrasodium EDTA, ethanol, and chlorhexidine, and wherein the composition has a pH of at least 9.5.
A peripheral line placement kit comprising:
- a peripheral line;
- and
- a solution chamber in communication with the peripheral line, wherein the solution chamber is configured to dispense a first disinfecting solution comprising 1-15% (w/v) tetrasodium EDTA, ethanol, chlorhexidine, and at least 1% (w/v) taurolidine, and wherein the composition has a pH of between 6.5 and 7.5 and is biocompatible in a bloodstream.
Dependencies are inferred from the claim text.